AI assistant
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012
Nov 9, 2012
30583_dirs_2012-11-09_907466d8-23b1-42b8-be5a-1c7e9aff96d5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-11-07
Reporting Person: HERON ELAINE J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-11-07 | Common Stock | M | 30000 | $7.46 | Acquired | 75900 | Direct |
| 2012-11-07 | Common Stock | M | 30000 | $14.93 | Acquired | 105900 | Direct |
| 2012-11-07 | Common Stock | M | 15000 | $17.33 | Acquired | 120900 | Direct |
| 2012-11-07 | Common Stock | M | 15000 | $38.59 | Acquired | 135900 | Direct |
| 2012-11-07 | Common Stock | M | 15000 | $14.39 | Acquired | 150900 | Direct |
| 2012-11-07 | Common Stock | S | 105000 | $46.4392 | Disposed | 45900 | Direct |
| 2012-11-09 | Common Stock | S | 30000 | $48.0117 | Disposed | 15900 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-11-07 | Stock Option (right to buy) | $7.46 | M | 30000 | Disposed | 2015-07-11 | Common Stock (30000) | Direct |
| 2012-11-07 | Stock Option (right to buy) Common Stock | $14.93 | M | 30000 | Disposed | 2016-07-11 | Common Stock (30000) | Direct |
| 2012-11-07 | Stock Option (right to buy) Common Stock | $17.33 | M | 15000 | Disposed | 2017-06-07 | Common Stock (15000) | Direct |
| 2012-11-07 | Stock Option (right to buy) Common Stock | $38.59 | M | 15000 | Disposed | 2018-05-21 | Common Stock (15000) | Direct |
| 2012-11-07 | Stock Option (right to buy) Common Stock | $14.39 | M | 15000 | Disposed | 2019-05-11 | Common Stock (15000) | Direct |
Footnotes
F1: The price in Column 4 is a weighted average price. The prices actually received ranged from $46.285 to $46.64. The reporting person will provide to the issue, any security holder of the issuer, or SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F2: The price in Column 4 is a weighted average price. The prices actually received ranged from $47.49 to $48.56. The reporting person will provide to the issue, any security holder of the issuer, or SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3: Options vest 1/4th each on October 12, 2005, January 12, 2006, April 12, 2006 and July 12, 2006.
F4: Options vest 1/4th each on October 12, 2006, Januray 12, 2007, April 12, 2007 and July 12, 2007.
F5: Options vest 1/4th each on September 7, 2007, December 7, 2007, March 7, 2008 and June 7, 2008.
F6: Options vest 1/4th each on August 22, 2008, November 22, 2008, February 22, 2009 and May 22, 2009.
F7: Options vest 1/4th each on August 12, 2009, November 12, 2009, February 12, 2010 and May 12, 2010.